To hear about similar clinical trials, please enter your email below

Trial Title: Assessment of Tobacco Smoking and Alcohol Drinking and Treatment Outcomes Among Patients With Lung or Head and Neck Cancer

NCT ID: NCT05523583

Condition: Lung or Head and Neck Cancer

Conditions: Official terms:
Head and Neck Neoplasms
Alcohol Drinking

Conditions: Keywords:
lung cancer
head and neck cancer
tabacco
alcohol

Study type: Observational

Overall status: Recruiting

Study design:

Time perspective: Prospective

Intervention:

Intervention type: Other
Intervention name: questionnaire
Description: A trained interviewer (Clinical Research Associate : CRA) will administer a questionnaire soon after the diagnosis on the phone (within 15 calendar days after diagnosis). The participants are followed up during the first year following the diagnosis through 3 follow-up assessments (at 3, 6, and 12 months after the baseline assessment) and hospital record reviews. At each follow-up, a brief questionnaire will be administered by an interviewer (CRA) via telephone.
Arm group label: Patients newly diagnosed with lung cancer or head & neck cancer

Other name: Tabacco and alcohol questionnaires

Summary: The overarching goal of the proposed study is to provide information which can lead to effective implementation of cessation support in the care of smokers diagnosed with lung or head & neck cancer. To achieve these aims, the study propose to conduct a longitudinal cohort study of patients diagnosed with lung or head & neck cancer at the Hospices Civils de Lyon (SMALLHAN). Briefly, adult patients newly diagnosed with lung or head & neck cancer will be recruited at the time of diagnosis (announcement of diagnosis and consultation).

Criteria for eligibility:

Study pop:
.): Patients treated in HCL, newly diagnosed with lung cancer or head & neck cancer (International Classification of Diseases 10: C76, C34) who undergo front-line treatment and who had at least one episode of smoking within the past 30 days before diagnosis

Sampling method: Non-Probability Sample
Criteria:
Inclusion Criteria: - Patients newly diagnosed with lung cancer or head & neck cancer (International Classification of Diseases 10: C76, C34) - Patients who undergo front-line treatment - Age 18 years or older - Benefiting from a Social Security scheme - Written information about the study provided to the patient before any procedure specific to the study - Patients who had at least one episode of smoking within the past 30 days before diagnosis Exclusion Criteria: - History of another lung or head & neck cancer < 5 years (Note: The presence of a second tumour location, discovered at the same time as the lung or head and neck cancer, does not constitute a non-inclusion criterion) - History of another cancer (except for curatively treated cervical cancer in situ and non-melanoma skin cancer) < 3 years - Mesothelioma, thymic malignancies, and cancer of the upper oesophagus - Inability to complete the study for psychosocial reasons (inability to schedule interview (homeless), no access to phone, psychological disorder leading to inability to answer phone interview, do not speak French and no easy access to translator from surroundings) - Patient under guardianship - Patient refusal

Gender: All

Minimum age: 18 Years

Maximum age: N/A

Healthy volunteers: No

Locations:

Facility:
Name: Hôpital Louis Pradel, Pneumologie

Address:
City: Bron
Zip: 69317
Country: France

Status: Recruiting

Contact:
Last name: Michaël DURUISSEAUX, MD

Phone: 427857700

Phone ext: +33
Email: michael.duruisseaux@chu-lyon.fr

Facility:
Name: Hôpital de la Croix-Rousse, Oto-Rhino-Laryngologie et Chirurgie Cervico-Faciale

Address:
City: Lyon
Zip: 69004
Country: France

Status: Recruiting

Contact:
Last name: Pierre PHILOUZE, MD

Phone: 426732770

Phone ext: +33
Email: pierre.philouze@chu-lyon.fr

Facility:
Name: Hôpital de la Croix-Rousse, Pneumologie

Address:
City: Lyon
Zip: 69004
Country: France

Status: Recruiting

Contact:
Last name: Lize KIAKOUAMA, MD

Phone: 472071730

Phone ext: +33
Email: lize.kiakouama@chu-lyon.fr

Facility:
Name: Hôpital Lyon Sud, Pneumologie

Address:
City: Pierre-Bénite
Zip: 69310
Country: France

Status: Recruiting

Contact:
Last name: Sébastien COURAUD, MD

Phone: 4 78 86 44 01

Phone ext: +33
Email: sebastien.couraud@chu-lyon.fr

Start date: October 27, 2022

Completion date: October 27, 2025

Lead sponsor:
Agency: Hospices Civils de Lyon
Agency class: Other

Collaborator:
Agency: International Agency for Research on Cancer
Agency class: Other

Source: Hospices Civils de Lyon

Record processing date: ClinicalTrials.gov processed this data on November 12, 2024

Source: ClinicalTrials.gov page: https://clinicaltrials.gov/ct2/show/NCT05523583

Login to your account

Did you forget your password?